Alzheimer’s patients are set to find out whether a new drug could become available in the UK as health regulators are poised ...

A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...

Health Alzheimer's Disease study plans to study 2,000 volunteers' brain scans and blood work to identify biomarkers of ...

Tim Sandry has an early form of Alzheimer’s disease, but considers himself fortunate to have started treatment with a promising new drug. “If there is a chance this will slow the progression ...

Scientists may have uncovered a new mechanism for treating Alzheimer's disease, offering hope to millions of patients worldwide. The discovery involves the activation of the brain's cellular clean-up ...

Neurophet has specialized in developing solutions for diagnosis support, treatment guides, and treatment devices targeting ...

After identifying that accumulation of toxic tau and amyloid proteins in the brain are a feature of Alzheimer’s disease, researchers have, understandably, been working on treatments that reduce ...

The approved drugs for Alzheimer’s disease do not address the underlying cause of the disease, but instead treat only the symptoms. However, there is a vast array of experimental treatments that are ...

Oct. 16, 2024 — Researchers used mouse models and human post-mortem brain tissue to study the molecular underpinnings that may increase the risk of Alzheimer's after ... Alzheimer's Disease May ...

[1,2] The treatment was tested in a large 18-month clinical study in patients with mild cognitive impairment (MCI) and mild dementia due to early AD. Even though you cannot stop AD from getting ...

Aricept is approved for all stages of AD, while Razadyne and Exelon are approved for the treatment of mild-to-moderate AD. Alzheimer’s damages cells that produce acetylcholine, which reduces the ...